Literature DB >> 32077934

Identification of an amino-terminus determinant critical for ryanodine receptor/Ca2+ release channel function.

Monika Seidel1,2, Camille Rabesahala de Meritens1,2, Louisa Johnson1,2, Dimitris Parthimos1,3, Mark Bannister1,2, Nia Lowri Thomas1,4, Esizaze Ozekhome-Mike1,2, Francis Anthony Lai5, Spyros Zissimopoulos1,2.   

Abstract

AIMS: The cardiac ryanodine receptor (RyR2), which mediates intracellular Ca2+ release to trigger cardiomyocyte contraction, participates in development of acquired and inherited arrhythmogenic cardiac disease. This study was undertaken to characterize the network of inter- and intra-subunit interactions regulating the activity of the RyR2 homotetramer. METHODS AND
RESULTS: We use mutational investigations combined with biochemical assays to identify the peptide sequence bridging the β8 with β9 strand as the primary determinant mediating RyR2 N-terminus self-association. The negatively charged side chains of two aspartate residues (D179 and D180) within the β8-β9 loop are crucial for the N-terminal inter-subunit interaction. We also show that the RyR2 N-terminus domain interacts with the C-terminal channel pore region in a Ca2+-independent manner. The β8-β9 loop is required for efficient RyR2 subunit oligomerization but it is dispensable for N-terminus interaction with C-terminus. Deletion of the β8-β9 sequence produces unstable tetrameric channels with subdued intracellular Ca2+ mobilization implicating a role for this domain in channel opening. The arrhythmia-linked R176Q mutation within the β8-β9 loop decreases N-terminus tetramerization but does not affect RyR2 subunit tetramerization or the N-terminus interaction with C-terminus. RyR2R176Q is a characteristic hypersensitive channel displaying enhanced intracellular Ca2+ mobilization suggesting an additional role for the β8-β9 domain in channel closing.
CONCLUSION: These results suggest that efficient N-terminus inter-subunit communication mediated by the β8-β9 loop may constitute a primary regulatory mechanism for both RyR2 channel activation and suppression.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Arrhythmia; Calcium signalling; Disease mechanism; Excitation-contraction coupling; Ryanodine receptor

Mesh:

Substances:

Year:  2021        PMID: 32077934      PMCID: PMC7898959          DOI: 10.1093/cvr/cvaa043

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  46 in total

1.  Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy.

Authors:  Prince J Kannankeril; Brett M Mitchell; Sanjeewa A Goonasekera; Mihail G Chelu; Wei Zhang; Subeena Sood; Debra L Kearney; Cristina I Danila; Mariella De Biasi; Xander H T Wehrens; Robia G Pautler; Dan M Roden; George E Taffet; Robert T Dirksen; Mark E Anderson; Susan L Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-27       Impact factor: 11.205

2.  The deletion of exon 3 in the cardiac ryanodine receptor is rescued by β strand switching.

Authors:  Paolo A Lobo; Lynn Kimlicka; Ching-Chieh Tung; Filip Van Petegem
Journal:  Structure       Date:  2011-06-08       Impact factor: 5.006

Review 3.  Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis.

Authors:  Silvia G Priori; S R Wayne Chen
Journal:  Circ Res       Date:  2011-04-01       Impact factor: 17.367

4.  The effects of low concentrations of caffeine on spontaneous Ca release in isolated rat ventricular myocytes.

Authors:  A W Trafford; G C Sibbring; M E Díaz; D A Eisner
Journal:  Cell Calcium       Date:  2000-10       Impact factor: 6.817

5.  Structural Basis for Gating and Activation of RyR1.

Authors:  Amédée des Georges; Oliver B Clarke; Ran Zalk; Qi Yuan; Kendall J Condon; Robert A Grassucci; Wayne A Hendrickson; Andrew R Marks; Joachim Frank
Journal:  Cell       Date:  2016-09-22       Impact factor: 41.582

6.  RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR).

Authors:  Dawei Jiang; Bailong Xiao; Dongmei Yang; Ruiwu Wang; Philip Choi; Lin Zhang; Heping Cheng; S R Wayne Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-20       Impact factor: 11.205

7.  FKBP12.6 binding of ryanodine receptors carrying mutations associated with arrhythmogenic cardiac disease.

Authors:  Spyros Zissimopoulos; N Lowri Thomas; Wan W Jamaluddin; F Anthony Lai
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

8.  Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death.

Authors:  N Lowri Thomas; Christopher H George; F Anthony Lai
Journal:  Cardiovasc Res       Date:  2004-10-01       Impact factor: 10.787

9.  Type 2 ryanodine receptor domain A contains a unique and dynamic α-helix that transitions to a β-strand in a mutant linked with a heritable cardiomyopathy.

Authors:  Fernando J Amador; Lynn Kimlicka; Peter B Stathopulos; Geneviève M C Gasmi-Seabrook; David H Maclennan; Filip Van Petegem; Mitsuhiko Ikura
Journal:  J Mol Biol       Date:  2013-08-23       Impact factor: 5.469

10.  Structural insights into Ca(2+)-activated long-range allosteric channel gating of RyR1.

Authors:  Risheng Wei; Xue Wang; Yan Zhang; Saptarshi Mukherjee; Lei Zhang; Qiang Chen; Xinrui Huang; Shan Jing; Congcong Liu; Shuang Li; Guangyu Wang; Yaofang Xu; Sujie Zhu; Alan J Williams; Fei Sun; Chang-Cheng Yin
Journal:  Cell Res       Date:  2016-08-30       Impact factor: 25.617

View more
  2 in total

Review 1.  Molecular, Subcellular, and Arrhythmogenic Mechanisms in Genetic RyR2 Disease.

Authors:  Ewan Douglas Fowler; Spyros Zissimopoulos
Journal:  Biomolecules       Date:  2022-07-26

2.  Impaired Binding to Junctophilin-2 and Nanostructural Alteration in CPVT Mutation.

Authors:  Liheng Yin; Alexandra Zahradnikova; Riccardo Rizzetto; Josefina Ramos-Franco; Esther Zorio; Spyros Zissimopoulos; Feliciano Protasi; Jean-Pierre Benitah; Simona Boncompagni; Camille Rabesahala de Meritens; Yadan Zhang; Pierre Joanne; Elena Marqués-Sulé; Yuriana Aguilar-Sánchez; Miguel Fernández-Tenorio; Olivier Villejoubert; Linwei Li; Yue Yi Wang; Philippe Mateo; Valérie Nicolas; Pascale Gerbaud; F Anthony Lai; Romain Perrier; Julio L Álvarez; Ernst Niggli; Héctor H Valdivia; Carmen R Valdivia; Ana M Gómez
Journal:  Circ Res       Date:  2021-06-11       Impact factor: 23.213

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.